glutathione gbm6 patient derived xenograft Frontiers Combination Treatment with the GSK-3
Description
Montelukast is a potent competitive antagonist (IC50 = 2.3 nM) at its target, the CysLT1 receptor
10.1007/s00709-014-0636-x 5 AnjumN
- Despertares nocturnos frecuentes donde el objetivo es mejorar continuidad del sueo
Integrative approaches for large-scale transcriptome-wide association studies
Research progress in extraction, structural characterization and biological activity of ginger polysaccharides
